Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report

@article{Saltmarche2017SignificantII,
  title={Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report},
  author={A. Saltmarche and M. Naeser and K. Ho and M. Hamblin and L. Lim},
  journal={Photomedicine and Laser Surgery},
  year={2017},
  volume={35},
  pages={432 - 441}
}
Abstract Objective: This study investigated whether patients with mild to moderately severe dementia or possible Alzheimer's disease (AD) with Mini-Mental State Exam (MMSE) Baseline scores of 10–24 would improve when treated with near-infrared photobiomodulation (PBM) therapy. Background: Animal studies have presented the potential of PBM for AD. Dysregulation of the brain's default mode network (DMN) has been associated with AD, presenting the DMN as an identifiable target for PBM. Materials… Expand
Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia
Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study
Photobiomodulation for Alzheimer's Disease: Has the Light Dawned?
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 45 REFERENCES
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
A phase II trial of huperzine A in mild to moderate Alzheimer disease
Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease
...
1
2
3
4
5
...